Clin Infect Dis
- WAN EYF, Chui CSL, Ng VWS, Wang Y, et al
mRNA (BNT162b2) COVID-19 vaccination increased risk of Bell's palsy: a nested
case control and self-controlled case series study.
Clin Infect Dis. 2022 Jun 8. pii: 6604461. doi: 10.1093.
- BART SM, Curtiss CC, Earnest R, Lobe-Costonis R, et al
SARS-CoV-2 Outbreak at a College with High COVID-19 Vaccination
Coverage-Connecticut, August-September 2021.
Clin Infect Dis. 2022 Jun 8. pii: 6604453. doi: 10.1093.
- LEWIS NM, Self WH, Gaglani M, Ginde AA, et al
Effectiveness of the Ad26.COV2.S (Johnson & Johnson) COVID-19 Vaccine for
Preventing COVID-19 Hospitalizations and Progression to High Disease Severity in
the United States.
Clin Infect Dis. 2022 Jun 8. pii: 6604454. doi: 10.1093.
- LEUNG NHL, Cheng SMS, Martin-Sanchez M, Au NYM, et al
Immunogenicity of a third dose of BNT162b2 to ancestral SARS-CoV-2 & Omicron
variant in adults who received two doses of inactivated vaccine.
Clin Infect Dis. 2022 Jun 8. pii: 6604400. doi: 10.1093.
- RICHTERMAN A, Behrman A, Brennan PJ, O'Donnell JA, et al
Durability of SARS-CoV-2 mRNA Booster Vaccine Protection Against Omicron Among
Health Care Workers with a Vaccine Mandate.
Clin Infect Dis. 2022 Jun 6. pii: 6603294. doi: 10.1093.
J Infect Dis
- BRUNHAM RC
Problems with Understanding Chlamydia trachomatis Immunology.
J Infect Dis. 2021 Dec 17. pii: 6469012. doi: 10.1093.
- LAPOINTE HR, Mwimanzi F, Cheung PK, Sang Y, et al
People with HIV receiving suppressive antiretroviral therapy show typical
antibody durability after dual COVID-19 vaccination, and strong third dose
responses.
J Infect Dis. 2022 Jun 7. pii: 6603521. doi: 10.1093.
- JACOBSON JM
Immune Responses to SARS-CoV-2 Vaccination in People With HIV: A Tale of Two
Pandemics.
J Infect Dis. 2022 Jun 7. pii: 6603522. doi: 10.1093.
- STORCH GA
Respiratory syncytial virus (RSV) around the globe: data to help guide wise use
of vaccines and anti-virals.
J Infect Dis. 2022 Jun 6. pii: 6603523. doi: 10.1093.
J Virol
- CHEN X, Li J, Yang L, Zhou Y, et al
Immunoglobin G Sero-Dynamics Aided Host Specific Linear Epitope Identification
and Differentiation of Infected from Vaccinated Hosts.
J Virol. 2022 Jun 6:e0014322. doi: 10.1128/jvi.00143.
MMWR Morb Mortal Wkly Rep
- KRISS JL, Hung MC, Srivastav A, Black CL, et al
COVID-19 Vaccination Coverage, by Race and Ethnicity - National Immunization
Survey Adult COVID Module, United States, December 2020-November 2021.
MMWR Morb Mortal Wkly Rep. 2022;71:757-763.
PLoS One
- JOSHI A, Surapaneni KM, Kaur M, Bhatt A, et al
A cross sectional study to examine factors influencing COVID-19 vaccine
acceptance, hesitancy and refusal in urban and rural settings in Tamil Nadu,
India.
PLoS One. 2022;17:e0269299.
- PATRICK L, Bakeera-Kitaka S, Rujumba J, Malande OO, et al
Encouraging improvement in HPV vaccination coverage among adolescent girls in
Kampala, Uganda.
PLoS One. 2022;17:e0269655.
- HILLS SL, Soeung SC, Sarath S, Morn C, et al
An evaluation of adverse events following an immunization campaign with the live,
attenuated SA14-14-2 Japanese encephalitis vaccine in Cambodia.
PLoS One. 2022;17:e0269480.
- ERCHICK DJ, Gupta M, Blunt M, Bansal A, et al
Understanding determinants of vaccine hesitancy and acceptance in India: A
qualitative study of government officials and civil society stakeholders.
PLoS One. 2022;17:e0269606.
- KHAIRKHAH N, Bolhassani A, Agi E, Namvar A, et al
Immunological investigation of a multiepitope peptide vaccine candidate based on
main proteins of SARS-CoV-2 pathogen.
PLoS One. 2022;17:e0268251.
- BITZENHOFER M, Suter-Riniker F, Moor MB, Sidler D, et al
Humoral response to mRNA vaccines against SARS-CoV-2 in patients with humoral
immunodeficiency disease.
PLoS One. 2022;17:e0268780.
- DARKWA S, de Wildt G, Dalaba M, Vidzro E, et al
"I would have to sell things in order to get the money": A qualitative
exploration of willingness to pay for the RTS,S/AS01 malaria vaccine in the Volta
region, Ghana.
PLoS One. 2022;17:e0268009.
- VILLANUEVA P, Wadia U, Crawford NW, Messina NL, et al
The safety of co-administration of Bacille Calmette-Guerin (BCG) and influenza
vaccines.
PLoS One. 2022;17:e0268042.
- MOSE A, Wasie A, Shitu S, Haile K, et al
Determinants of COVID-19 vaccine acceptance in Ethiopia: A systematic review and
meta-analysis.
PLoS One. 2022;17:e0269273.
Proc Natl Acad Sci U S A
- AMERICO JL, Cotter CA, Earl PL, Liu R, et al
Intranasal inoculation of an MVA-based vaccine induces IgA and protects the
respiratory tract of hACE2 mice from SARS-CoV-2 infection.
Proc Natl Acad Sci U S A. 2022;119:e2202069119.
- OTIANG E, Yoder J, Manian S, Campbell ZA, et al
Vaccination of household chickens results in a shift in young children's diet and
improves child growth in rural Kenya.
Proc Natl Acad Sci U S A. 2022;119:e2122389119.
- NARCISO AR, Iovino F, Thorsdottir S, Mellroth P, et al
Membrane particles evoke a serotype-independent cross-protection against
pneumococcal infection that is dependent on the conserved lipoproteins MalX and
PrsA.
Proc Natl Acad Sci U S A. 2022;119:e2122386119.
Science
- KUPFERSCHMIDT K
Monkeypox vaccination plans take shape amid questions.
Science. 2022;376:1142-1143.
Vaccine
- TOOR J, Li X, Jit M, Trotter CL, et al
COVID-19 impact on routine immunisations for vaccine-preventable diseases:
Projecting the effect of different routes to recovery.
Vaccine. 2022 May 30. pii: S0264-410X(22)00698.
- WATANABE A, Nishida S, Burcu T, Shibahara T, et al
Safety and immunogenicity of a quadrivalent seasonal influenza vaccine adjuvanted
with hydroxypropyl-beta-cyclodextrin: A phase 1 clinical trial.
Vaccine. 2022 Jun 4. pii: S0264-410X(22)00677.
- AB RAHMAN N, Lim MT, Lee FY, Lee SC, et al
Risk of serious adverse events after the BNT162b2, CoronaVac, and ChAdOx1
vaccines in Malaysia: A self-controlled case series study.
Vaccine. 2022 Jun 3. pii: S0264-410X(22)00700.
- JANSSEN DF
A familiar species of Crank: Anti-Vaccinationists in medical history.
Vaccine. 2022 Jun 3. pii: S0264-410X(22)00665.
- WOO EJ, Dimova RB
Thrombocytopenia after Ad.26.COV2.S COVID-19 vaccine: Reports to the vaccine
adverse event reporting system.
Vaccine. 2022 May 30. pii: S0264-410X(22)00704.
- BILGIN GM, Lokuge K, Glass K
Modelling the impact of maternal pneumococcal vaccination on infant pneumococcal
disease in low-income settings.
Vaccine. 2022 Jun 3. pii: S0264-410X(22)00684.
- PATEL KM, Shafiq M, Malik AA, Cobanoglu A, et al
Relationship between the use of nonpharmaceutical interventions and COVID-19
vaccination among U.S. child care providers: A prospective cohort study.
Vaccine. 2022 May 27. pii: S0264-410X(22)00680.
- PILLSBURY M, Carias C, Samant S, Greenberg D, et al
Comparison of performance of varicella vaccines via infectious disease modeling.
Vaccine. 2022 May 31. pii: S0264-410X(22)00574.
- HISYAM BIN ISMAIL CMK, Raihan Mohammad Shabani N, Chuah C, Hassan Z, et al
Shigella iron-binding proteins: An insight into molecular physiology,
pathogenesis, and potential target vaccine development.
Vaccine. 2022 May 31. pii: S0264-410X(22)00679.
- MERRICK E, Weissman JP, Patel SJ
Utilizing Google trends to monitor coronavirus vaccine interest and hesitancies.
Vaccine. 2022 May 30. pii: S0264-410X(22)00699.
- SOEGIARTO G, Wulandari L, Purnomosari D, Dhia Fahmita K, et al
Hypertension is associated with antibody response and breakthrough infection in
health care workers following vaccination with inactivated SARS-CoV-2.
Vaccine. 2022 May 27. pii: S0264-410X(22)00676.
- EVANS B, Jombart T
Worldwide routine immunisation coverage regressed during the first year of the
COVID-19 pandemic.
Vaccine. 2022;40:3531-3535.
- SPARROW E, Adetifa I, Chaiyakunapruk N, Cherian T, et al
WHO preferred product characteristics for monoclonal antibodies for passive
immunization against respiratory syncytial virus (RSV) disease in infants - Key
considerations for global use.
Vaccine. 2022;40:3506-3510.
- POLLET J, Strych U, Chen WH, Versteeg L, et al
Receptor-binding domain recombinant protein on alum-CpG induces broad protection
against SARS-CoV-2 variants of concern.
Vaccine. 2022;40:3655-3663.
- OSTER G, Bornheimer R, Ottino K, Stevenson C, et al
Adult immunization against hepatitis B: Does the number of jabs matter?
Vaccine. 2022 May 12. pii: S0264-410X(22)00534.
- SCHENK J, Abrams S, Litzroth A, Cornelissen L, et al
Identifying immunity gaps for measles using Belgian serial serology data.
Vaccine. 2022;40:3676-3683.
- LEIGH JP, Moss SJ, White TM, Picchio CA, et al
Factors affecting COVID-19 vaccine hesitancy among healthcare providers in 23
countries.
Vaccine. 2022 May 5. pii: S0264-410X(22)00545.
- DUBE C, Paris-Robidas S, Andreani G, Gutzeit C, et al
Broad neutralization against SARS-CoV-2 variants induced by ancestral and B.1.351
AS03-Adjuvanted recombinant Plant-Derived Virus-Like particle vaccines.
Vaccine. 2022 May 27. pii: S0264-410X(22)00641.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016